Company Filing History:
Years Active: 2014
Title: Innovations of Nicholas LoConte
Introduction
Nicholas LoConte is an accomplished inventor based in Winthrop, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds that serve as inhibitors of ATR protein kinase. His work has implications for treating various diseases and disorders.
Latest Patents
LoConte holds a patent for "Compounds useful as inhibitors of ATR kinase." This invention relates to compounds that inhibit ATR protein kinase, along with pharmaceutically acceptable compositions that include these compounds. The patent also covers methods for treating diseases using these compounds, processes for their preparation, and their application in in vitro studies of kinases and intracellular signal transduction pathways. The compounds are defined by specific formulas, which include variations and pharmaceutically acceptable salts.
Career Highlights
Nicholas LoConte is currently associated with Vertex Pharmaceuticals, Inc., a leading biotechnology company. His work at Vertex focuses on innovative solutions in drug development, particularly in the realm of kinase inhibitors. His contributions have been instrumental in advancing therapeutic options for patients.
Collaborations
LoConte has collaborated with notable colleagues, including Jean-Damien Charrier and Pierre-Henri Storck. These collaborations have fostered a productive environment for research and development, enhancing the impact of their collective work in the field.
Conclusion
Nicholas LoConte's innovative work in developing ATR kinase inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies in treating complex diseases.